Physician

Adam S Morgenthau, M.D.

According to 2025 Medicare claims, Adam Morgenthau, M.D. (NPI: 1013986496) practices pulmonary disease in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (NPI: 1518228550; TIN: 611661781) and primary practice location at 10029-6030. Morgenthau is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Morgenthau's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 223 traditional Medicare patients, billed 676 HCPCS/CPT codes, and received $43,670 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 662 prescription claims across 112 beneficiaries totaling $294,288 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 122 claims. Open Payments data shows 2 records totaling $23,170. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $87,312 to $43,670. In contrast, Part D prescription costs have moved sharply higher in recent years, from $88,805 to $294,288. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $3,917 and ending at $6,855.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	641	1,773	$87,312
2016	579	1,570	$65,894
2017	460	1,163	$51,240
2018	541	1,402	$63,827
2019	477	1,296	$60,532
2020	383	861	$48,496
2021	441	1,095	$57,493
2022	280	685	$46,676
2023	186	595	$42,640
2024	223	676	$43,670

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	599	$88,805
2016	82	426	$69,519
2017	81	432	$82,909
2018	82	395	$85,998
2019	71	375	$78,747
2020	94	505	$109,023
2021	85	453	$233,232
2022	94	537	$279,825
2023	99	595	$327,828
2024	112	662	$294,288

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	40	$2,147
2016	N/R	44	$2,512
2017	N/R	16	$900
2018	N/R	N/R	N/R
2019	N/R	67	$3,047
2020	N/R	110	$5,175
2021	N/R	145	$6,086
2022	N/R	39	$2,033
2023	N/R	73	$3,603
2024	N/R	122	$6,726

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	40	40	$145
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	97	151	$120
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	49	88	$102
94375	Test to measure rate of airflow	113	157	$12
94729	Test to examine how well the lungs exchange gases	106	141	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	22	750	$184,985
Advair Hfa	Fluticasone Propion/Salmeterol	16	930	$10,963
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	660	$10,114
Incruse Ellipta	Umeclidinium Bromide	12	660	$7,463
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	660	$3,339

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	66	$4,715
E1392	Portable oxygen concentrator, rental	Y	N/R	56	$2,011

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$23,170	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam S. Morgenthau, M.D.?

Tedicare shows public-source Medicare data for Adam S. Morgenthau, M.D. (NPI 1013986496), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam S. Morgenthau, M.D. have ACO affiliation data?

Adam S. Morgenthau, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Adam S. Morgenthau, M.D.?

Adam S. Morgenthau, M.D. is linked to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (billing NPI 1518228550) in the available physician profile data.

Does Adam S. Morgenthau, M.D. have Open Payments data?

Adam S. Morgenthau, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.